Skip to content

Mindfulness-Based Smoking Cessation Delivered Through Telehealth and Text Messaging for Low-Income Smokers: Protocol for a Randomized Controlled Trial

Claire Adams Spears, Josephine Mhende, China Hawkins, Van Vuong, Matthew J. Hayat, Michael Paul Eriksen, Donald Hedeker, Lorien C. Abroms, David W. Wetter

JMIR Research Protocols August 1, 2022 DOI: 10.2196/35688 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial protocol Peer reviewed
Population Low-income, racially and ethnically diverse adults who smoke
Interventions iQuit Mindfully text messages mindfulness videoconference groups
Duration Treatment start with assessments at 8, 12, and 24 weeks; data collection expected through spring 2024
Topics Meditation
Citations 6
Registration NCT04965181
Key findings The authors propose testing whether mindfulness-based smoking cessation treatment delivered via text messaging (iQuit Mindfully) and telehealth group videoconferencing, alone or combined, improves biochemically verified smoking abstinence at 8, 12, and 24 weeks among low-income and racially and ethnically diverse adults who smoke, and aims to examine mechanisms of mindfulness treatment.

Abstract

Background: Tobacco use is the leading cause of preventable morbidity and mortality. Adults with low income and members of certain racial and ethnic minority groups are less likely to quit, and therefore, they experience profound tobacco-related health disparities. Mindfulness training can increase the rates of smoking cessation and lapse recovery, and telehealth and SMS text messaging have the potential to provide more accessible treatment.

Objective: This study aims to test the efficacy of delivering mindfulness-based smoking cessation treatment through text messaging (iQuit Mindfully) and telehealth (group videoconferencing), both as stand-alone interventions and in combination. In addition, it aims to examine the underlying mechanisms of mindfulness treatment.

Methods: In this 2×2 randomized controlled trial, participants are randomized into 1 of 4 groups based on assignment to iQuit Mindfully text messages (yes or no) and mindfulness videoconference groups (yes or no). The primary outcomes are biochemically verified smoking abstinence at 8, 12, and 24 weeks after the start of treatment. Secondary outcomes include the frequency of home mindfulness practice and self-reported levels of mindfulness, emotions, craving, withdrawal, dependence, self-efficacy, and social support.

Results: Recruitment, treatment, and assessment began in spring and summer 2021, and data collection is expected to continue through spring 2024.

Conclusions: This project aims to improve smoking cessation outcomes for low-income, racially and ethnically diverse smokers through mindfulness-based telehealth group counseling and text messaging support. We also aim to advance the scientific study of the mechanisms of action of mindfulness treatment, which could inform the development of more efficacious and efficient treatments to reduce tobacco disparities.

Trial Registration: Clinicaltrials.gov NCT04965181; https://clinicaltrials.gov/ct2/show/NCT04965181. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/35688.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics